Skip to content
DRP Journal

DRP Journal

Discover Research Profit

  • Home
  • About
  • Contact

NASDAQ:ATOS

Finance 

Atossa Therapeutics (NASDAQ:ATOS) Stock Falls Sharply From The Recent Peak

July 26, 2021July 30, 2021 Pete Matthews ATOS, ATOS news, ATOS stock, Atossa Therapeutics Inc. (NASDAQ:ATOS), NASDAQ:ATOS

Those investors who are currently looking into the possibility of investing in biopharmaceutical stocks could do well to take a

Read more
Finance 

Atossa Therapeutics (NASDAQ:ATOS) Stock Slips Below $4: Should You Buy Or Ignore?

July 20, 2021July 30, 2021 Ash K ATOS, ATOS news, ATOS stock, Atossa Therapeutics Inc. (NASDAQ:ATOS), NASDAQ:ATOS

Investors can attempt to trade clinical-stage biopharmaceutical firm Atossa Therapeutics (NASDAQ:ATOS) either by buying or holding the shares. Shares of the

Read more
Finance 

Atossa Therapeutics (NASDAQ:ATOS) Stock Slips Over 50% From The Peak: A Good Buy?

July 17, 2021July 30, 2021 Jon Williams ATOS, ATOS news, ATOS stock, Atossa Therapeutics Inc. (NASDAQ:ATOS), NASDAQ:ATOS

The COVID 19 pandemic might be abating but companies are still working on treatments for it and one of the

Read more
Finance 

Atossa Therapeutics Inc. (NASDAQ:ATOS) stock Rockets 565% YTD: Will it Hot $10?

July 14, 2021July 30, 2021 Madison Hall ATOS, ATOS news, ATOS stock, Atossa Therapeutics Inc. (NASDAQ:ATOS), NASDAQ:ATOS

Atossa Therapeutics Inc. (NASDAQ:ATOS) stock has been among the top-performing stocks this year, and it is up 565% year to

Read more

Featured

ZenaTech’s (Nasdaq: ZENA) Nasdaq Listing: A Launchpad for Growth and Innovation
Featured Finance 

ZenaTech’s (Nasdaq: ZENA) Nasdaq Listing: A Launchpad for Growth and Innovation

October 2, 2024October 2, 2024 Riley McKelvie

ZenaTech (Nasdaq:ZENA) made its debut on the Nasdaq, a pivotal milestone for the company specializing in AI-driven drone solutions and

Panther Minerals Inc. (CSE: PURR) (OTC: GLIOF) Gears Up for Growth in the Uranium Revival
Featured Finance 

Panther Minerals Inc. (CSE: PURR) (OTC: GLIOF) Gears Up for Growth in the Uranium Revival

August 14, 2024August 14, 2024 Riley McKelvie
Diamonds of Tomorrow: Adamas One Corp. (NASDAQ: JEWL) and the Lab-Grown Evolution
Featured 

Diamonds of Tomorrow: Adamas One Corp. (NASDAQ: JEWL) and the Lab-Grown Evolution

April 4, 2024April 4, 2024 Mark Mckelvie
4 Stocks with Exposure to the Growing Asian and Middle Eastern EV Markets
Featured 

4 Stocks with Exposure to the Growing Asian and Middle Eastern EV Markets

April 4, 2024April 4, 2024 Riley McKelvie
4 Stocks That Will Benefit From The Green Energy Revolution
Featured 

4 Stocks That Will Benefit From The Green Energy Revolution

April 4, 2024April 4, 2024 Mark Mckelvie
4 Uranium Stocks Set to Soar in 2024 (FUUFF, DNN, CCJ, NXE)
Featured 

4 Uranium Stocks Set to Soar in 2024 (FUUFF, DNN, CCJ, NXE)

December 18, 2023December 18, 2023 Mark Mckelvie
OTC Stocks News Catalyst Watchlist (FDCT, NEXCF, SPZI, IFUS)
Featured Finance 

OTC Stocks News Catalyst Watchlist (FDCT, NEXCF, SPZI, IFUS)

December 11, 2023December 11, 2023 Mark Mckelvie
HippoFi Hires World’s Top Regenerative Therapy Expert Dr. Gail Naughton to Drive Commercialization Plans of its Proprietary Technologies
Featured 

HippoFi Hires World’s Top Regenerative Therapy Expert Dr. Gail Naughton to Drive Commercialization Plans of its Proprietary Technologies

December 8, 2023December 8, 2023 Riley McKelvie

DRPJournal.com
Discover, Research, Profit
15505 Cedarwood Ln #104
Naples, FL, 34110

Phone 585 301 7700

email: MarkrMcKelvie@gmail.com

Disclaimer

Discover - Research - Profit

  • Home
  • About
  • Contact
Copyright © 2025 DRP Journal. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.